Acyl-Coenzyme A:Cholesterol Acyltransferase 2 (ACAT2) Is Induced in Monocyte-Derived Macrophages: In Vivo and in Vitro Studies

Laboratory Investigation

Volumn 83, Issue 11, 2003, Pages 1569-1581

  Sakashita, Naomi ^a,c   Miyazaki, Akira ^b   Chang, Catherine C Y ^c   Chang, Ta Yuan ^c   Kiyota, Emi ^a   Satoh, Maki ^a   Komohara, Yoshihiro ^a   Morganelli, Peter M ^d   Horiuchi, Seikoh ^a   Takeya, Motohiro ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A CHOLESTEROL ACYLTRANSFERASE 2; CHOLESTEROL ACYLTRANSFERASE; ENZYME ANTIBODY; LIPID; MESSENGER RNA; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL CULTURE; CELL DIFFERENTIATION; CONGENITAL DISORDER; CONTROLLED STUDY; EXUDATE; FOAM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; IMMUNOBLOTTING; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL DETECTION;

ANIMALS; AORTA; ARTERIOSCLEROSIS; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOAM CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKOCYTES, MONONUCLEAR; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROL O-ACYLTRANSFERASE;

EID: 10744224292     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000095687.17383.39     Document Type: Article

References (36)

1. Accad M, Smith SJ, Newland DL, Sanan DA, King LE, Linton MF, Fazio S, and Farese RV (2000). Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J Clin Invest 105:711-719.
2. Anderson RA, Joyce C, Davis M, Reagan JW, Clark M, Shelness GS, and Rudel LL (1998). Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primate. J Biol Chem 273:26747-26754.
3. Brown MS and Goldstein JL (1983). Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52:223-261.
4. Buhman KK, Accad M, Novak S, Choi RS, Wong JS, Hamilton RL, Turley S, and Farese RV Jr (2000). Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med 6:1341-1347.
5. Cases S, Novak S, Zheng YW, Myers HM, Lear SR, Sande E, Welch CB, Lusis AJ, Spencer TA, Krause BR, Erickson SK, and Farese RV Jr (1998). ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase: Its cloning, expression and characterization. J Biol Chem 273:26755-26764.
6. Chang CC, Chen J, Thomas MA, Cheng D, Del Priore VA, Newton RS, Pape ME, and Chang TY (1995). Regulation and immunolocalization of acyl-coenzyme A:cholesterol acyltransferase in mammalian cells as studied with specific antibodies. J Biol Chem 270:29532-29540.
7. Chang CC, Lee CY, Chang ET, Cruz JC, Levesque MC, and Chang TY (1998). Recombinant acyl-CoA:cholesterol acyltransferase-1 (ACAT-1) purified to essential homogeneity utilizes cholesterol in mixed micelles or in vesicles in a highly cooperative manner. J Biol Chem 273:35132-35141.
8. Chang CCY, Huh HY, Cadigan KM, and Chang TY (1993). Molecular cloning and functional expression of human acylcoenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J Biol Chem 268:20747-20755.
9. Chang CCY, Sakashita N, Ornvold K, Lee O, Chang ET, Dong R, Lin S, Lee Chi-Yu G, Strom SC, Kashyap R, Fung JJ, Farase RV Jr., Patoiseau J-F, Delhon A, and Chang TY (2000). Immunological quantitation and localization of ACAT-1 and ACAT-1 in human liver and small intestine. J Biol Chem 275:28083-28092.
10. Chang TY, Chang CC, Lin S, Yu C, Li BL, and Miyazaki A (2001). Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2. Curr Opin Lipidol 12:289-296.
11. Chang TY, Chang CCY, and Cheng D (1997). Acyl-coenzyme A:cholesterol acyltransferase. Annu Rev Biochem 66:613-638.
12. Cheng W, Kvilekval KV, and Abumrad NA (1995). Dexamethasone enhances accumulation of cholesteryl esters by human macrophages. Am J Physiol 269:E642-E648.
13. Facchetti F, de Wolf-Peeters C, Mason DY, Pulford K, van den Oord JJ, and Desmet VJ (1988). Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin. Am J Pathol 133:15-21.
14. Gown AM, Tsukada T, and Ross R (1986). Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 125:191-207.
15. Hagiwara SI, Takeya M, Suzuki H, Kodama T, van der Laan LJ, Kraal G, Kitamura N, and Takahashi K (1999). Role of macrophage scavenger receptors in hepatic granuloma formation in mice. Am J Pathol 154:705-720.
16. Isobe S, Nakane PK, and Brown WR (1977). Studies on translocation of immunoglobulins across intestinal epithelium. I. Improvements in the peroxidase-labeled antibody method for application to study of human intestinal mucosa Acta Histochem Cytochem 10:161-171.
17. Johnson WD, Mei B, and Cohn ZA (1977). The separation, long-term cultivation, and maturation of the human monocyte. J Exp Med 146:1613-1626.
18. Joyce C, Skinner K, Anderson RA, and Rudel LL (1999). Acyl-coenzyme A:cholesteryl acyltransferase 2. Curr Opin Lipidol 10:89-95.
19. Lee O, Chang CCY, Lee W, and Chang TY (1998). Immmunodepletion experiments suggest that acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1) protein plays a major catalytic role in adult human liver, adrenal gland, macrophages, and kidney, but not intestine. J Lipid Res 39:1722-1727.
20. Lee RG, Willingham MC, Davis MA, Skinner KA, and Rudel LL (2000). Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney and adrenal of nonhuman primates. J Lipid Res 41:1991-2001.
21. Matsuda K (1994). ACAT inhibitors as antiatherosclerotic agents: Compounds and mechanisms. Med Res Rev 14:271-305.
22. 3 or 9-cis-retinoic acid in undifferentiated THP-1 cells. J Lipid Res 42:181-187.
23. Meiner VL, Cases S, Myers HM, Sande ER, Bellosta S, Schambelan M, Pitas RE, McGuire J, Herz J, and Farese RV Jr (1996). Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: Evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci USA 93:14041-14046.
24. Miyazaki A, Sakashita N, Lee O, Takahashi K, Horiuchi S, Hakamata H, Morganelli PM, Chang CC, and Chang TY (1998). Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler Thromb Vasc Biol 18:1568-1574.
25. Oelkers P, Behari A, Cromley D, Billheimer JT, and Sturley SL (1998). Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes. J Biol Chem 273:26765-26771.
26. Panousis CG and Zuckerman SH (2000). Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding cassette transporter 1) in macrophage-derived foam cells. Arterioscler Thromb Vasc Biol 20:1423-1424.
27. Pape ME, Schultz PA, Rea TJ, DeMattos RB, Kieft K, Bisgaier CL, Newton RS, and Krause BR (1995). Tissue specific changes in acyl-CoA:cholesterol acyltransferase (ACAT) mRNA levels in rabbits. J Lipid Res 36:823-838.
28. Pulford KA, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC, and Mason DY (1989). KP1: A new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 42:414-421.
29. Ross R (1986). The pathogenesis of atherosclerosis: An update. N Engl J Med 314:448-500.
30. Sakai M, Miyazaki A, Hakamata H, Sato Y, Matsumura T, Koborl S, Shichiri M, and Horiuchi S (1996). Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 16:600-605.
31. Sakashita N, Miyazaki A, Takeya M, Horiuchi S, Chang CC, Chang TY, and Takahashi K (2000). Localization of human acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues. Am J Pathol 156:227-236.
32. Tabas I (1995). The stimulation of the cholesterol esterification pathway by atherogenic lipoproteins in macrophages. Curr Opin Lipidol 6:260-268.
33. Tsukada T, Tippens D, Gordon D, Ross R, and Gown AM (1987). HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization Am J Pathol 126:51-60.
34. Yagyu H, KitamineT, Osuga J, Tozawa R, Chen Z, Kaji Y, Oka T, Perry S, Tamura Y, Ohashi K, Okazaki H, Yahagi H, Shionoiri F, Iizuka Y, Harada K, Shimano H, Yamashita H, Gotoda T, Yamada N, and Ishibashi S (2000). Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem 275:21324-20998.
35. Yang JB, Duan ZJ, Yao W, Lee O, Yang L, Yang XY, Sun X, Chang CC, Chang TY, and Li BL (2001). Synergistic transcriptional activation of human Acyl-coenzyme A:cholesterol acyltransferase-1 gene by interferon-gamma and all-transretinoic acid THP-1 cells. J Biol Chem 276:20989-20998.
36. Zuckerman SH, Ackerman SK, and Douglas SD (1979). Long-term human peripheral blood monocyte cultures: Establishment, metabolism and morphology of primary human monocyte-macrophage cell cultures. Immunology 38:401-411.